BIO-RAD LABORATORIES, INC.
BIO BIO.B
20 insider filings · Latest: Sep 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 28, 2026 | May 28 7:04 PM | Alles Institute for Medical Research Corp | Proposed Sale | 700 | $313.28 | $219.3K | — | View → |
| May 11, 2026 | May 13 7:38 PM | Eva Anette EngelhardtEVP, President, CDG | Sale | 550 | $246.54 | $135.6K | 346(D) | View → |
| May 11, 2026 | May 11 9:03 PM | EVA ENGELHARDT | Proposed Sale | 550 | $246.54 | $135.6K | — | View → |
| Dec 2, 2025 | Dec 2 11:27 PM | MICHAEL W CROWLEY | Proposed Sale | 776 | $319.56 | $248.0K | — | View → |
| Nov 18, 2025 | Nov 18 6:03 PM | Alles Institute for Medical Research Corp | Proposed Sale | 760 | $301.04 | $228.8K | — | View → |
| Nov 6, 2025 | Nov 6 9:24 PM | JAMES BARRY | Proposed Sale | 701 | $306.18 | $214.6K | — | View → |
| Aug 5, 2025 | Aug 5 8:47 PM | MICHAEL W CROWLEY | Proposed Sale | 1,488 | $275.92 | $410.6K | — | View → |
| Mar 13, 2025 | Mar 13 9:17 PM | Crowley Michael | Proposed Sale | 3,000 | $260.00 | $780.0K | — | View → |
| Mar 11, 2025 | Mar 11 4:36 PM | Alles Institute for Medical Research Corp | Proposed Sale | 410 | $247.66 | $101.5K | — | View → |
| Nov 6, 2024 | Nov 6 11:26 PM | Last Andrew J. | Proposed Sale | 3,000 | $373.64 | $1.1M | — | View → |
| Sep 12, 2024 | Sep 12 10:22 PM | Last Andrew J. | Proposed Sale | 1,600 | $321.57 | $514.5K | — | View → |
| Sep 6, 2024 | Sep 6 8:16 PM | Last Andrew J. | Proposed Sale | 3,000 | $329.94 | $989.8K | — | View → |
| Sep 4, 2024 | Sep 4 10:24 PM | BARRY JAMES | Proposed Sale | 623 | $330.49 | $205.9K | — | View → |
| Aug 27, 2024 | Aug 27 4:45 PM | Alles Institute for Medical Research Corp | Proposed Sale | 990 | $311.34 | $308.2K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 6, 2026 | Sep 9 10:47 PM | Schwartz AllisonDirector | Option Exercise | 92 | — | 185(D) | View → |
| Sep 5, 2026 | Sep 9 10:47 PM | Schwartz AllisonDirector | Option Exercise | 228 | — | 686(D) | View → |
| Sep 4, 2026 | Sep 9 10:47 PM | Schwartz AllisonDirector | Grant/Award | 719 | — | 719(D) | View → |
| Sep 6, 2026 | Sep 9 10:46 PM | James BarryEVP, President, LSG | Option Exercise | 1,056 | — | 2,112(D) | View → |
| Sep 5, 2026 | Sep 9 10:46 PM | James BarryEVP, President, LSG | Option Exercise | 1,027 | — | 3,083(D) | View → |
| Sep 4, 2026 | Sep 9 10:46 PM | James BarryEVP, President, LSG | Grant/Award | 4,313 | — | 4,313(D) | View → |
| Sep 6, 2026 | Sep 9 10:46 PM | Sedat EvranEVP, Global Supply Chain | Option Exercise | 864 | — | 1,728(D) | View → |
| Sep 5, 2026 | Sep 9 10:46 PM | Sedat EvranEVP, Global Supply Chain | Option Exercise | 1,027 | — | 3,083(D) | View → |
| Sep 4, 2026 | Sep 9 10:46 PM | Sedat EvranEVP, Global Supply Chain | Grant/Award | 4,026 | — | 4,026(D) | View → |
| Sep 6, 2026 | Sep 9 10:45 PM | Eva Anette EngelhardtEVP, President, CDG | Option Exercise | 1,152 | — | 2,304(D) | View → |
| Sep 5, 2026 | Sep 9 10:45 PM | Eva Anette EngelhardtEVP, President, CDG | Option Exercise | 1,027 | — | 3,083(D) | View → |
| Sep 4, 2026 | Sep 9 10:45 PM | Eva Anette EngelhardtEVP, President, CDG | Grant/Award | 4,313 | — | 4,313(D) | View → |
| Sep 5, 2026 | Sep 9 10:45 PM | Jonathan P. DivincenzoPresident & COO | Option Exercise | 1,712 | — | 5,138(D) | View → |
| Sep 4, 2026 | Sep 9 10:45 PM | Jonathan P. DivincenzoPresident & COO | Grant/Award | 6,326 | — | 6,326(D) | View → |
| Sep 6, 2026 | Sep 9 10:45 PM | Courtney C EnloeEVP, General Counsel & Sec | Option Exercise | 768 | — | 1,536(D) | View → |
| Sep 5, 2026 | Sep 9 10:45 PM | Courtney C EnloeEVP, General Counsel & Sec | Option Exercise | 685 | — | 2,055(D) | View → |
| Sep 4, 2026 | Sep 9 10:45 PM | Courtney C EnloeEVP, General Counsel & Sec | Grant/Award | 2,876 | — | 2,876(D) | View → |
| Sep 5, 2026 | Sep 9 10:44 PM | Rajat MehtaEVP, GBL Commercial Operations | Option Exercise | 1,826 | — | 4,110(D) | View → |
| Sep 4, 2026 | Sep 9 10:44 PM | Rajat MehtaEVP, GBL Commercial Operations | Grant/Award | 4,601 | — | 4,601(D) | View → |
| Sep 6, 2026 | Sep 9 10:42 PM | Roop Kalyan LakkarajuEVP, Chief Financial Officer | Option Exercise | 1,536 | — | 3,072(D) | View → |
Page 1 of 2
Next →